Co-Authors
This is a "connection" page, showing publications co-authored by Susan Fink and Chihiro Morishima.
Connection Strength
0.985
-
Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS One. 2021; 16(9):e0255841.
Score: 0.241
-
Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun. 2020; 3:100073.
Score: 0.229
-
Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results. Emerg Infect Dis. 2020 10; 26(10):2501-2503.
Score: 0.224
-
Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity. J Clin Microbiol. 2021 08 18; 59(9):e0098921.
Score: 0.060
-
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e165.
Score: 0.060
-
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates. J Clin Invest. 2021 02 01; 131(3).
Score: 0.058
-
SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa535.
Score: 0.057
-
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J Clin Microbiol. 2020 07 23; 58(8).
Score: 0.056